Bank Analysts Downgraded These Shares August 4th

Following is information on companies for which stock analysts downgraded shares today:

  • MEMC Elec (NYSE:WFR): Ardour Capital downgraded its rating on this stock from Buy to Accumulate and changed its price target from $16 to $8.5. Kaufman Bros downgraded its rating on this stock from Buy to Hold and changed its price target from $10 to $7.  About the company: MEMC Electronic Materials, Inc. produces silicon wafers.  The Company’s products are used in computers, telecommunications equipment, automobiles, consumer electronics products, industrial automation and control systems, and analytical and defense systems.  MEMC operates manufacturing facilities in Italy, Japan, Malaysia, South Korea, Taiwan, and the United States. MEMC Electronic Materials Earnings Cheat Sheet: Beats Estimates>>
  • Lamar Advertising (NASDAQ:LAMR): The Benchmark Company downgraded its rating on this stock from Buy to Hold and changed its price target from $33 to $24.  About the company: Lamar Advertising Company owns and operates outdoor advertising structures in the United States.  The Company provides poster and bulletin displays, as well as logo signs.  Lamar also operates tourism signage franchises in the United States and Canada.
  • Clorox (NYSE:CLX): Caris & Company downgraded its rating on this stock from Average to Below Average and gave a price target of $60.  About the company: The Clorox Company produces and markets non-durable consumer products sold primarily through grocery and other retail stores.  The Company’s principal products include household cleaning and bleach products, charcoal, cat litter, automotive care products, dressings, and trash bags.  Clorox markets its products in the United States and other countries around the world.
  • NCI (NASDAQ:NCIT): Stifel Nicolaus downgraded its rating on this company from Buy to Hold.  No price target was given.  About the company: NCI, Inc. designs, installs and maintains information technology systems and networks for government agencies.  The Company offers network engineering, information assurance, systems development and integration, and enterprise systems management services.
  • El Paso Electric (NYSE:EE): Ticonderoga downgraded its rating on this company from Buy to Neutral.  No price target was given.  About the company: El Paso Electric Company generates, distributes, and transmits electricity in west Texas and southern New Mexico.  The Company also serves wholesale customers in Texas, New Mexico, California, and Mexico.  El Paso Electric owns or has partial ownership interests in electrical generating facilities.
  • NetSpend (NASDAQ:NTSP): Barrington Research downgraded its rating on this company from Outperform to Mkt Perform.  No price target was given.  About the company:  Netspend Holdings, Inc. issues reloadable prepaid debit cards.  The Company primarily serves people who don’t have bank deposit accounts.
  • Walter Energy (NYSE:WLT): Brean Murray downgraded its rating on this stock from Buy to Hold.  No price target was given.  About the company: Walter Energy, Inc. mines coal.  The Company produces metallurgical and steam and industrial coal; manufactures blast furnace, foundry, industrial and buckwheat coke; and produces light oil, coal tar, and ammonium sulfate.  Walter Energy also degasifies coalbeds and sells the gas to a utility.
  • Dendreon (NASDAQ:DNDN): Brean Murray downgraded its rating on this stock from Buy to Sell and changed its price target from $60 to $6. Needham downgraded its rating on this company from Buy to Hold.   No price target was given. Collins Stewart downgraded its rating on this stock from Buy to Neutral and changed its price target from $55 to $19.  Robert W. Baird downgraded its rating on this stock from Outperform to Neutral and changed its price target from $56 to $20.  About the company: Dendreon Corporation discovers and develops immunologically based therapeutic products for the treatment of cancer.  The Company combines knowledge in immunology and antigen engineering with proprietary cell separation technologies to develop therapeutic vaccines that induce cell-mediates immunity, the body’s key defense against cancer.

(Note: Data on stock ratings are sourced from here.  All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter >>